CA2100314A1 - Preparation pharmaceutique pour le traitement de l'ulcere chronique de la peau - Google Patents

Preparation pharmaceutique pour le traitement de l'ulcere chronique de la peau

Info

Publication number
CA2100314A1
CA2100314A1 CA 2100314 CA2100314A CA2100314A1 CA 2100314 A1 CA2100314 A1 CA 2100314A1 CA 2100314 CA2100314 CA 2100314 CA 2100314 A CA2100314 A CA 2100314A CA 2100314 A1 CA2100314 A1 CA 2100314A1
Authority
CA
Canada
Prior art keywords
treatment
pharmaceutical composition
skin ulcers
chronic skin
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2100314
Other languages
English (en)
Other versions
CA2100314C (fr
Inventor
Pierre Rochon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2100314 priority Critical patent/CA2100314C/fr
Priority to FR9408541A priority patent/FR2707497A1/fr
Priority to GB9413939A priority patent/GB2280370A/en
Priority to DE19944424548 priority patent/DE4424548A1/de
Publication of CA2100314A1 publication Critical patent/CA2100314A1/fr
Application granted granted Critical
Publication of CA2100314C publication Critical patent/CA2100314C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CA 2100314 1993-07-12 1993-07-12 Preparation pharmaceutique pour le traitement de l'ulcere chronique de la peau Expired - Fee Related CA2100314C (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA 2100314 CA2100314C (fr) 1993-07-12 1993-07-12 Preparation pharmaceutique pour le traitement de l'ulcere chronique de la peau
FR9408541A FR2707497A1 (fr) 1993-07-12 1994-07-11 Composition pharmaceutique pour le traitement des ulcères chroniques de la peau.
GB9413939A GB2280370A (en) 1993-07-12 1994-07-11 Pharmaceutical composition for the treatment of chronic skin ulcers
DE19944424548 DE4424548A1 (de) 1993-07-12 1994-07-12 Pharmazeutische Zusammensetzung zur Behandlung chronischer Ulzera der Haut

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2100314 CA2100314C (fr) 1993-07-12 1993-07-12 Preparation pharmaceutique pour le traitement de l'ulcere chronique de la peau

Publications (2)

Publication Number Publication Date
CA2100314A1 true CA2100314A1 (fr) 1995-01-13
CA2100314C CA2100314C (fr) 1996-04-16

Family

ID=4151918

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2100314 Expired - Fee Related CA2100314C (fr) 1993-07-12 1993-07-12 Preparation pharmaceutique pour le traitement de l'ulcere chronique de la peau

Country Status (4)

Country Link
CA (1) CA2100314C (fr)
DE (1) DE4424548A1 (fr)
FR (1) FR2707497A1 (fr)
GB (1) GB2280370A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100222301A1 (en) * 2010-02-06 2010-09-02 Javid Mihan Jafari Topical drug for treatment and/or prevention of diabetic neuropathy, microangiopathy and diabetic and non diabetic ulcers and wound infection

Also Published As

Publication number Publication date
GB2280370A (en) 1995-02-01
FR2707497A1 (fr) 1995-01-20
CA2100314C (fr) 1996-04-16
GB9413939D0 (en) 1994-08-31
DE4424548A1 (de) 1995-01-19

Similar Documents

Publication Publication Date Title
CA2274074A1 (fr) Nouveaux composes a effet analgesique
CA2239174A1 (fr) Nouveaux composes a effet analgesique
CA2180816A1 (fr) 6-dimethylaminomethyl-1-phenylcyclohexanes, principes actifs en pharmacie
CA2193337A1 (fr) Composes de type 1-phenyl-2-dimethylaminomethylcyclohexan-1-o1, ingredients pharmaceutiques actifs
ITMI922953A1 (it) Inibitori a doppia attivita' biologica di no sintasi e cicloossigenasi procedimento per la loro preparazione e composizioni terapeutiche che li contengono.
CA2068324A1 (fr) Compositions peptidiques renfermant un metal et methodes de stimulation de la croissance des cheveux
MY132705A (en) Novel compounds with analgesic effect
EP1466606A3 (fr) Utilisation de l'inosine dans la fabrication d'un medicament pour stimuler l'excroissance des neurons du système nerveux central
AU5201493A (en) Method and pharmaceutical preparations for reducing the activity of cells
AU4697393A (en) Pharmaceutical and/or cosmetic preparation and the use of the preparation
CA2094137A1 (fr) Nouveau derive d'acide hydroxamique et de n-hydroxyuree; leur utilisation
CA2186269A1 (fr) Cicatrisation
DE69631609D1 (en) Tricyclische erythromycinderivate
AU7001487A (en) Difluorohalomethoxyphenyl derivative and miticide comprising said derivative as active ingredient
CA2139385A1 (fr) Produits renfermant une proteine liante de g-csf et de tnf
CA2200480A1 (fr) Nouvelle utilisation de prostaglandines
WO1994008613A3 (fr) Utilisation de parathormone, de ses fragments a activite biologique et de peptides associes pour le traitement de problemes de grossesse
CA2031817A1 (fr) Utilisation de la thrombospondine pour favoriser la cicatrisation
AU7588094A (en) Dihalopropene compound, insecticide/acaricide containing said diahalopropene compound as active ingredient, and intermediate compound for use in production of said dihalopropene compound
DE69723864D1 (en) Ethyliden-derivate tricyclyscher carbapenems
EP0393707A3 (fr) Composés bio-actifs associés à des liposomes et leur utilisation dans des préparations pharmaceutiques
AU591892B2 (en) Peptides
CA2120319A1 (fr) Compose pharmaceutique pour le traitement des dermatopathies
ITMI922742A0 (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
CA2100314A1 (fr) Preparation pharmaceutique pour le traitement de l'ulcere chronique de la peau

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed